0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Human Papilloma Virus Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-5L6130
Home | Market Reports | Computers & Electronics
Global Human Papilloma Virus Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Human Papilloma Virus Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5L6130
Report
September 2024
Pages:149
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Papilloma Virus Testing - Market Size

The global market for Human Papilloma Virus Testing was estimated to be worth US$ 757 million in 2023 and is forecast to a readjusted size of US$ 1103.2 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030

Human Papilloma Virus Testing - Market

Human Papilloma Virus Testing - Market

Human Papilloma Virus Testing is the procedure to test if the patient have the Human Papilloma Virus
North American market for Human Papilloma Virus Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Papilloma Virus Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Human Papilloma Virus Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Human Papilloma Virus Testing include Roche, AgilentTechnologies, Inc., Becton, DickinsonandCompany, QiagenN.V., ThermoFisherScientificInc., AbbottLaboratories, HologicInc., CepheidInc. and SeegenEInc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Papilloma Virus Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Human Papilloma Virus Testing by region & country, by Type, and by Application.
The Human Papilloma Virus Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Papilloma Virus Testing.
Market Segmentation

Scope of Human Papilloma Virus Testing - Market Report

Report Metric Details
Report Name Human Papilloma Virus Testing - Market
Forecasted market size in 2030 US$ 1103.2 million
CAGR 5.4%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Diagnostic Centers
  • Hospitals
  • Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, AgilentTechnologies, Inc., Becton, DickinsonandCompany, QiagenN.V., ThermoFisherScientificInc., AbbottLaboratories, HologicInc., CepheidInc., SeegenEInc., TakarABioInc., DaAnGenECo., Ltd.of SunYat-SenUniversity, PromegACorporation, GreinerBio-OnEInternationalGmbH(GreinerHoldingAG), EnzoBiochemInc., NorgenBiotek Corp., DiagCorBiosciencEIncLtd, HybribioLimited, ZytovisionGmbH, ArborVitACorporation, Medical& BiologicalLaboratoriesCo., Ltd, Fujirebio Diagnostics, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Human Papilloma Virus Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Human Papilloma Virus Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Human Papilloma Virus Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Human Papilloma Virus Testing - Market size in 2030?

Ans: The Human Papilloma Virus Testing - Market size in 2030 will be US$ 1103.2 million.

Who are the main players in the Human Papilloma Virus Testing - Market report?

Ans: The main players in the Human Papilloma Virus Testing - Market are Roche, AgilentTechnologies, Inc., Becton, DickinsonandCompany, QiagenN.V., ThermoFisherScientificInc., AbbottLaboratories, HologicInc., CepheidInc., SeegenEInc., TakarABioInc., DaAnGenECo., Ltd.of SunYat-SenUniversity, PromegACorporation, GreinerBio-OnEInternationalGmbH(GreinerHoldingAG), EnzoBiochemInc., NorgenBiotek Corp., DiagCorBiosciencEIncLtd, HybribioLimited, ZytovisionGmbH, ArborVitACorporation, Medical& BiologicalLaboratoriesCo., Ltd, Fujirebio Diagnostics, Inc.

What are the Application segmentation covered in the Human Papilloma Virus Testing - Market report?

Ans: The Applications covered in the Human Papilloma Virus Testing - Market report are Diagnostic Centers, Hospitals, Clinic

What are the Type segmentation covered in the Human Papilloma Virus Testing - Market report?

Ans: The Types covered in the Human Papilloma Virus Testing - Market report are Pap Smear Test, HPV DNA Test

Recommended Reports

HPV & Cervical Diagnostics

Virus Diagnostic Kits

HPV Vaccines & Treatments

1 Market Overview
1.1 Human Papilloma Virus Testing Product Introduction
1.2 Global Human Papilloma Virus Testing Market Size Forecast
1.3 Human Papilloma Virus Testing Market Trends & Drivers
1.3.1 Human Papilloma Virus Testing Industry Trends
1.3.2 Human Papilloma Virus Testing Market Drivers & Opportunity
1.3.3 Human Papilloma Virus Testing Market Challenges
1.3.4 Human Papilloma Virus Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Papilloma Virus Testing Players Revenue Ranking (2023)
2.2 Global Human Papilloma Virus Testing Revenue by Company (2019-2024)
2.3 Key Companies Human Papilloma Virus Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Human Papilloma Virus Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Human Papilloma Virus Testing
2.6 Human Papilloma Virus Testing Market Competitive Analysis
2.6.1 Human Papilloma Virus Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Human Papilloma Virus Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papilloma Virus Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pap Smear Test
3.1.2 HPV DNA Test
3.2 Global Human Papilloma Virus Testing Sales Value by Type
3.2.1 Global Human Papilloma Virus Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Papilloma Virus Testing Sales Value, by Type (2019-2030)
3.2.3 Global Human Papilloma Virus Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Diagnostic Centers
4.1.2 Hospitals
4.1.3 Clinic
4.2 Global Human Papilloma Virus Testing Sales Value by Application
4.2.1 Global Human Papilloma Virus Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Papilloma Virus Testing Sales Value, by Application (2019-2030)
4.2.3 Global Human Papilloma Virus Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Human Papilloma Virus Testing Sales Value by Region
5.1.1 Global Human Papilloma Virus Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Papilloma Virus Testing Sales Value by Region (2019-2024)
5.1.3 Global Human Papilloma Virus Testing Sales Value by Region (2025-2030)
5.1.4 Global Human Papilloma Virus Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Human Papilloma Virus Testing Sales Value, 2019-2030
5.2.2 North America Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Human Papilloma Virus Testing Sales Value, 2019-2030
5.3.2 Europe Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Human Papilloma Virus Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Human Papilloma Virus Testing Sales Value, 2019-2030
5.5.2 South America Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Human Papilloma Virus Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Papilloma Virus Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Papilloma Virus Testing Sales Value
6.3 United States
6.3.1 United States Human Papilloma Virus Testing Sales Value, 2019-2030
6.3.2 United States Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Papilloma Virus Testing Sales Value, 2019-2030
6.4.2 Europe Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Papilloma Virus Testing Sales Value, 2019-2030
6.5.2 China Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Papilloma Virus Testing Sales Value, 2019-2030
6.6.2 Japan Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Papilloma Virus Testing Sales Value, 2019-2030
6.7.2 South Korea Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Papilloma Virus Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Papilloma Virus Testing Sales Value, 2019-2030
6.9.2 India Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Papilloma Virus Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Human Papilloma Virus Testing Products, Services and Solutions
7.1.4 Roche Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 AgilentTechnologies, Inc.
7.2.1 AgilentTechnologies, Inc. Profile
7.2.2 AgilentTechnologies, Inc. Main Business
7.2.3 AgilentTechnologies, Inc. Human Papilloma Virus Testing Products, Services and Solutions
7.2.4 AgilentTechnologies, Inc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.2.5 AgilentTechnologies, Inc. Recent Developments
7.3 Becton, DickinsonandCompany
7.3.1 Becton, DickinsonandCompany Profile
7.3.2 Becton, DickinsonandCompany Main Business
7.3.3 Becton, DickinsonandCompany Human Papilloma Virus Testing Products, Services and Solutions
7.3.4 Becton, DickinsonandCompany Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.3.5 QiagenN.V. Recent Developments
7.4 QiagenN.V.
7.4.1 QiagenN.V. Profile
7.4.2 QiagenN.V. Main Business
7.4.3 QiagenN.V. Human Papilloma Virus Testing Products, Services and Solutions
7.4.4 QiagenN.V. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.4.5 QiagenN.V. Recent Developments
7.5 ThermoFisherScientificInc.
7.5.1 ThermoFisherScientificInc. Profile
7.5.2 ThermoFisherScientificInc. Main Business
7.5.3 ThermoFisherScientificInc. Human Papilloma Virus Testing Products, Services and Solutions
7.5.4 ThermoFisherScientificInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.5.5 ThermoFisherScientificInc. Recent Developments
7.6 AbbottLaboratories
7.6.1 AbbottLaboratories Profile
7.6.2 AbbottLaboratories Main Business
7.6.3 AbbottLaboratories Human Papilloma Virus Testing Products, Services and Solutions
7.6.4 AbbottLaboratories Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.6.5 AbbottLaboratories Recent Developments
7.7 HologicInc.
7.7.1 HologicInc. Profile
7.7.2 HologicInc. Main Business
7.7.3 HologicInc. Human Papilloma Virus Testing Products, Services and Solutions
7.7.4 HologicInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.7.5 HologicInc. Recent Developments
7.8 CepheidInc.
7.8.1 CepheidInc. Profile
7.8.2 CepheidInc. Main Business
7.8.3 CepheidInc. Human Papilloma Virus Testing Products, Services and Solutions
7.8.4 CepheidInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.8.5 CepheidInc. Recent Developments
7.9 SeegenEInc.
7.9.1 SeegenEInc. Profile
7.9.2 SeegenEInc. Main Business
7.9.3 SeegenEInc. Human Papilloma Virus Testing Products, Services and Solutions
7.9.4 SeegenEInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.9.5 SeegenEInc. Recent Developments
7.10 TakarABioInc.
7.10.1 TakarABioInc. Profile
7.10.2 TakarABioInc. Main Business
7.10.3 TakarABioInc. Human Papilloma Virus Testing Products, Services and Solutions
7.10.4 TakarABioInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.10.5 TakarABioInc. Recent Developments
7.11 DaAnGenECo., Ltd.of SunYat-SenUniversity
7.11.1 DaAnGenECo., Ltd.of SunYat-SenUniversity Profile
7.11.2 DaAnGenECo., Ltd.of SunYat-SenUniversity Main Business
7.11.3 DaAnGenECo., Ltd.of SunYat-SenUniversity Human Papilloma Virus Testing Products, Services and Solutions
7.11.4 DaAnGenECo., Ltd.of SunYat-SenUniversity Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.11.5 DaAnGenECo., Ltd.of SunYat-SenUniversity Recent Developments
7.12 PromegACorporation
7.12.1 PromegACorporation Profile
7.12.2 PromegACorporation Main Business
7.12.3 PromegACorporation Human Papilloma Virus Testing Products, Services and Solutions
7.12.4 PromegACorporation Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.12.5 PromegACorporation Recent Developments
7.13 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG)
7.13.1 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Profile
7.13.2 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Main Business
7.13.3 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Human Papilloma Virus Testing Products, Services and Solutions
7.13.4 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.13.5 GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Recent Developments
7.14 EnzoBiochemInc.
7.14.1 EnzoBiochemInc. Profile
7.14.2 EnzoBiochemInc. Main Business
7.14.3 EnzoBiochemInc. Human Papilloma Virus Testing Products, Services and Solutions
7.14.4 EnzoBiochemInc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.14.5 EnzoBiochemInc. Recent Developments
7.15 NorgenBiotek Corp.
7.15.1 NorgenBiotek Corp. Profile
7.15.2 NorgenBiotek Corp. Main Business
7.15.3 NorgenBiotek Corp. Human Papilloma Virus Testing Products, Services and Solutions
7.15.4 NorgenBiotek Corp. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.15.5 NorgenBiotek Corp. Recent Developments
7.16 DiagCorBiosciencEIncLtd
7.16.1 DiagCorBiosciencEIncLtd Profile
7.16.2 DiagCorBiosciencEIncLtd Main Business
7.16.3 DiagCorBiosciencEIncLtd Human Papilloma Virus Testing Products, Services and Solutions
7.16.4 DiagCorBiosciencEIncLtd Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.16.5 DiagCorBiosciencEIncLtd Recent Developments
7.17 HybribioLimited
7.17.1 HybribioLimited Profile
7.17.2 HybribioLimited Main Business
7.17.3 HybribioLimited Human Papilloma Virus Testing Products, Services and Solutions
7.17.4 HybribioLimited Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.17.5 HybribioLimited Recent Developments
7.18 ZytovisionGmbH
7.18.1 ZytovisionGmbH Profile
7.18.2 ZytovisionGmbH Main Business
7.18.3 ZytovisionGmbH Human Papilloma Virus Testing Products, Services and Solutions
7.18.4 ZytovisionGmbH Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.18.5 ZytovisionGmbH Recent Developments
7.19 ArborVitACorporation
7.19.1 ArborVitACorporation Profile
7.19.2 ArborVitACorporation Main Business
7.19.3 ArborVitACorporation Human Papilloma Virus Testing Products, Services and Solutions
7.19.4 ArborVitACorporation Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.19.5 ArborVitACorporation Recent Developments
7.20 Medical& BiologicalLaboratoriesCo., Ltd
7.20.1 Medical& BiologicalLaboratoriesCo., Ltd Profile
7.20.2 Medical& BiologicalLaboratoriesCo., Ltd Main Business
7.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papilloma Virus Testing Products, Services and Solutions
7.20.4 Medical& BiologicalLaboratoriesCo., Ltd Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Developments
7.21 Fujirebio Diagnostics, Inc.
7.21.1 Fujirebio Diagnostics, Inc. Profile
7.21.2 Fujirebio Diagnostics, Inc. Main Business
7.21.3 Fujirebio Diagnostics, Inc. Human Papilloma Virus Testing Products, Services and Solutions
7.21.4 Fujirebio Diagnostics, Inc. Human Papilloma Virus Testing Revenue (US$ Million) & (2019-2024)
7.21.5 Fujirebio Diagnostics, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Human Papilloma Virus Testing Industrial Chain
8.2 Human Papilloma Virus Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Papilloma Virus Testing Sales Model
8.5.2 Sales Channel
8.5.3 Human Papilloma Virus Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Human Papilloma Virus Testing Market Trends
    Table 2. Human Papilloma Virus Testing Market Drivers & Opportunity
    Table 3. Human Papilloma Virus Testing Market Challenges
    Table 4. Human Papilloma Virus Testing Market Restraints
    Table 5. Global Human Papilloma Virus Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Human Papilloma Virus Testing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Human Papilloma Virus Testing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Human Papilloma Virus Testing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Human Papilloma Virus Testing
    Table 10. Global Human Papilloma Virus Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papilloma Virus Testing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Human Papilloma Virus Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Human Papilloma Virus Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Human Papilloma Virus Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Human Papilloma Virus Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Human Papilloma Virus Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Human Papilloma Virus Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Human Papilloma Virus Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Human Papilloma Virus Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Human Papilloma Virus Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Human Papilloma Virus Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Human Papilloma Virus Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Human Papilloma Virus Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Human Papilloma Virus Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Human Papilloma Virus Testing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Human Papilloma Virus Testing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Human Papilloma Virus Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Human Papilloma Virus Testing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Human Papilloma Virus Testing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Roche Basic Information List
    Table 32. Roche Description and Business Overview
    Table 33. Roche Human Papilloma Virus Testing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Human Papilloma Virus Testing Business of Roche (2019-2024)
    Table 35. Roche Recent Developments
    Table 36. AgilentTechnologies, Inc. Basic Information List
    Table 37. AgilentTechnologies, Inc. Description and Business Overview
    Table 38. AgilentTechnologies, Inc. Human Papilloma Virus Testing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Human Papilloma Virus Testing Business of AgilentTechnologies, Inc. (2019-2024)
    Table 40. AgilentTechnologies, Inc. Recent Developments
    Table 41. Becton, DickinsonandCompany Basic Information List
    Table 42. Becton, DickinsonandCompany Description and Business Overview
    Table 43. Becton, DickinsonandCompany Human Papilloma Virus Testing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Human Papilloma Virus Testing Business of Becton, DickinsonandCompany (2019-2024)
    Table 45. Becton, DickinsonandCompany Recent Developments
    Table 46. QiagenN.V. Basic Information List
    Table 47. QiagenN.V. Description and Business Overview
    Table 48. QiagenN.V. Human Papilloma Virus Testing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Human Papilloma Virus Testing Business of QiagenN.V. (2019-2024)
    Table 50. QiagenN.V. Recent Developments
    Table 51. ThermoFisherScientificInc. Basic Information List
    Table 52. ThermoFisherScientificInc. Description and Business Overview
    Table 53. ThermoFisherScientificInc. Human Papilloma Virus Testing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Human Papilloma Virus Testing Business of ThermoFisherScientificInc. (2019-2024)
    Table 55. ThermoFisherScientificInc. Recent Developments
    Table 56. AbbottLaboratories Basic Information List
    Table 57. AbbottLaboratories Description and Business Overview
    Table 58. AbbottLaboratories Human Papilloma Virus Testing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Human Papilloma Virus Testing Business of AbbottLaboratories (2019-2024)
    Table 60. AbbottLaboratories Recent Developments
    Table 61. HologicInc. Basic Information List
    Table 62. HologicInc. Description and Business Overview
    Table 63. HologicInc. Human Papilloma Virus Testing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Human Papilloma Virus Testing Business of HologicInc. (2019-2024)
    Table 65. HologicInc. Recent Developments
    Table 66. CepheidInc. Basic Information List
    Table 67. CepheidInc. Description and Business Overview
    Table 68. CepheidInc. Human Papilloma Virus Testing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Human Papilloma Virus Testing Business of CepheidInc. (2019-2024)
    Table 70. CepheidInc. Recent Developments
    Table 71. SeegenEInc. Basic Information List
    Table 72. SeegenEInc. Description and Business Overview
    Table 73. SeegenEInc. Human Papilloma Virus Testing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Human Papilloma Virus Testing Business of SeegenEInc. (2019-2024)
    Table 75. SeegenEInc. Recent Developments
    Table 76. TakarABioInc. Basic Information List
    Table 77. TakarABioInc. Description and Business Overview
    Table 78. TakarABioInc. Human Papilloma Virus Testing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Human Papilloma Virus Testing Business of TakarABioInc. (2019-2024)
    Table 80. TakarABioInc. Recent Developments
    Table 81. DaAnGenECo., Ltd.of SunYat-SenUniversity Basic Information List
    Table 82. DaAnGenECo., Ltd.of SunYat-SenUniversity Description and Business Overview
    Table 83. DaAnGenECo., Ltd.of SunYat-SenUniversity Human Papilloma Virus Testing Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Human Papilloma Virus Testing Business of DaAnGenECo., Ltd.of SunYat-SenUniversity (2019-2024)
    Table 85. DaAnGenECo., Ltd.of SunYat-SenUniversity Recent Developments
    Table 86. PromegACorporation Basic Information List
    Table 87. PromegACorporation Description and Business Overview
    Table 88. PromegACorporation Human Papilloma Virus Testing Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Human Papilloma Virus Testing Business of PromegACorporation (2019-2024)
    Table 90. PromegACorporation Recent Developments
    Table 91. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Basic Information List
    Table 92. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Description and Business Overview
    Table 93. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Human Papilloma Virus Testing Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Human Papilloma Virus Testing Business of GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) (2019-2024)
    Table 95. GreinerBio-OnEInternationalGmbH(GreinerHoldingAG) Recent Developments
    Table 96. EnzoBiochemInc. Basic Information List
    Table 97. EnzoBiochemInc. Description and Business Overview
    Table 98. EnzoBiochemInc. Human Papilloma Virus Testing Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Human Papilloma Virus Testing Business of EnzoBiochemInc. (2019-2024)
    Table 100. EnzoBiochemInc. Recent Developments
    Table 101. NorgenBiotek Corp. Basic Information List
    Table 102. NorgenBiotek Corp. Description and Business Overview
    Table 103. NorgenBiotek Corp. Human Papilloma Virus Testing Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Human Papilloma Virus Testing Business of NorgenBiotek Corp. (2019-2024)
    Table 105. NorgenBiotek Corp. Recent Developments
    Table 106. DiagCorBiosciencEIncLtd Basic Information List
    Table 107. DiagCorBiosciencEIncLtd Description and Business Overview
    Table 108. DiagCorBiosciencEIncLtd Human Papilloma Virus Testing Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Human Papilloma Virus Testing Business of DiagCorBiosciencEIncLtd (2019-2024)
    Table 110. DiagCorBiosciencEIncLtd Recent Developments
    Table 111. HybribioLimited Basic Information List
    Table 112. HybribioLimited Description and Business Overview
    Table 113. HybribioLimited Human Papilloma Virus Testing Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Human Papilloma Virus Testing Business of HybribioLimited (2019-2024)
    Table 115. HybribioLimited Recent Developments
    Table 116. ZytovisionGmbH Basic Information List
    Table 117. ZytovisionGmbH Description and Business Overview
    Table 118. ZytovisionGmbH Human Papilloma Virus Testing Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Human Papilloma Virus Testing Business of ZytovisionGmbH (2019-2024)
    Table 120. ZytovisionGmbH Recent Developments
    Table 121. ArborVitACorporation Basic Information List
    Table 122. ArborVitACorporation Description and Business Overview
    Table 123. ArborVitACorporation Human Papilloma Virus Testing Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Human Papilloma Virus Testing Business of ArborVitACorporation (2019-2024)
    Table 125. ArborVitACorporation Recent Developments
    Table 126. Medical& BiologicalLaboratoriesCo., Ltd Basic Information List
    Table 127. Medical& BiologicalLaboratoriesCo., Ltd Description and Business Overview
    Table 128. Medical& BiologicalLaboratoriesCo., Ltd Human Papilloma Virus Testing Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Human Papilloma Virus Testing Business of Medical& BiologicalLaboratoriesCo., Ltd (2019-2024)
    Table 130. Medical& BiologicalLaboratoriesCo., Ltd Recent Developments
    Table 131. Fujirebio Diagnostics, Inc. Basic Information List
    Table 132. Fujirebio Diagnostics, Inc. Description and Business Overview
    Table 133. Fujirebio Diagnostics, Inc. Human Papilloma Virus Testing Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Human Papilloma Virus Testing Business of Fujirebio Diagnostics, Inc. (2019-2024)
    Table 135. Fujirebio Diagnostics, Inc. Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Human Papilloma Virus Testing Downstream Customers
    Table 139. Human Papilloma Virus Testing Distributors List
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
    Table 143. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Human Papilloma Virus Testing Product Picture
    Figure 2. Global Human Papilloma Virus Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Human Papilloma Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Human Papilloma Virus Testing Report Years Considered
    Figure 5. Global Human Papilloma Virus Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Papilloma Virus Testing Revenue in 2023
    Figure 7. Human Papilloma Virus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Pap Smear Test Picture
    Figure 9. HPV DNA Test Picture
    Figure 10. Global Human Papilloma Virus Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Human Papilloma Virus Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Diagnostic Centers
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Clinic
    Figure 15. Global Human Papilloma Virus Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Human Papilloma Virus Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Human Papilloma Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Human Papilloma Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Human Papilloma Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Human Papilloma Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Human Papilloma Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Human Papilloma Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Human Papilloma Virus Testing Sales Value (%), (2019-2030)
    Figure 28. United States Human Papilloma Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Human Papilloma Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Human Papilloma Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Human Papilloma Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Human Papilloma Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Human Papilloma Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Human Papilloma Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Human Papilloma Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Human Papilloma Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Human Papilloma Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Human Papilloma Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Human Papilloma Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Human Papilloma Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Human Papilloma Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Human Papilloma Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 49. Human Papilloma Virus Testing Industrial Chain
    Figure 50. Human Papilloma Virus Testing Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure